These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 10629022

  • 1. Levofloxacin in vitro activity and time-kill evaluation of Stenotrophomonas maltophilia clinical isolates.
    Bonfiglio G, Cascone C, Azzarelli C, Cafiso V, Marchetti F, Stefani S.
    J Antimicrob Chemother; 2000 Jan; 45(1):115-7. PubMed ID: 10629022
    [Abstract] [Full Text] [Related]

  • 2. Comparative in vitro activity of levofloxacin and ciprofloxacin against bacterial isolates from neutropenic patients.
    Di Bonaventura G, D'Antonio D, Catamo G, D'Ercole S, Piccolomini R.
    Chemotherapy; 2002 Jul; 48(3):134-7. PubMed ID: 12138329
    [Abstract] [Full Text] [Related]

  • 3. Antimicrobial susceptibility of stenotrophomonas maltophilia isolates from Korea, and the activity of antimicrobial combinations against the isolates.
    Chung HS, Hong SG, Kim YR, Shin KS, Whang DH, Ahn JY, Park YJ, Uh Y, Chang CL, Shin JH, Lee HS, Lee K, Chong Y.
    J Korean Med Sci; 2013 Jan; 28(1):62-6. PubMed ID: 23341713
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Antimicrobial susceptibility profile of contemporary clinical strains of Stenotrophomonas maltophilia isolates: can moxifloxacin activity be predicted by levofloxacin MIC results?
    Galles AC, Jones RN, Sader HS.
    J Chemother; 2008 Feb; 20(1):38-42. PubMed ID: 18343741
    [Abstract] [Full Text] [Related]

  • 6. Activity of levofloxacin and ciprofloxacin on biofilms and planktonic cells of Stenotrophomonas maltophilia isolates from patients with device-associated infections.
    Passerini de Rossi B, García C, Calenda M, Vay C, Franco M.
    Int J Antimicrob Agents; 2009 Sep; 34(3):260-4. PubMed ID: 19362452
    [Abstract] [Full Text] [Related]

  • 7. In vitro synergistic/additive activity of levofloxacin with meropenem against Stenotrophomonas maltophilia.
    Pankey GA, Ashcraft DS.
    Diagn Microbiol Infect Dis; 2010 Jul; 67(3):297-300. PubMed ID: 20542209
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Resistance of Stenotrophomonas maltophilia to Fluoroquinolones: Prevalence in a University Hospital and Possible Mechanisms.
    Jia W, Wang J, Xu H, Li G.
    Int J Environ Res Public Health; 2015 May 13; 12(5):5177-95. PubMed ID: 25985315
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Levofloxacin and ciprofloxacin in vitro activities against 4,003 clinical bacterial isolates collected in 24 Italian laboratories.
    Gesu GP, Marchetti F, Piccoli L, Cavallero A.
    Antimicrob Agents Chemother; 2003 Feb 13; 47(2):816-9. PubMed ID: 12543701
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Levofloxacin Efflux and smeD in Clinical Isolates of Stenotrophomonas maltophilia.
    Chong SY, Lee K, Chung HS, Hong SG, Suh Y, Chong Y.
    Microb Drug Resist; 2017 Mar 13; 23(2):163-168. PubMed ID: 27294684
    [Abstract] [Full Text] [Related]

  • 18. Activity of Delafloxacin and Levofloxacin against Stenotrophomonas maltophilia at Simulated Plasma and Intrapulmonary pH Values.
    Vialichka A, Biagi M, Meyer K, Wu T, Shajee A, Tan X, Wenzler E.
    Microbiol Spectr; 2022 Aug 31; 10(4):e0270521. PubMed ID: 35862943
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.